Business Segments Shanghai Shyndec Pharmaceutical Co., Ltd.
Equities
600420
CNE000001JG2
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.71 CNY | +1.61% |
|
+2.88% | +6.04% |
| Jan. 13 | Shyndec Pharmaceutical's Generic Drug Secures Approval for Antibiotic Consistency Evaluation | MT |
| Dec. 26 | Shyndec Pharmaceutical Gets China Nod for Antipsychotic | MT |
Sales 2024 by Business Segment
Sales 2024 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Pharmaceutical Products | ||||||||||
Pharmaceuticals Segment | 12.56B | 13.94B | 12.96B | 12.07B | 10.94B | |||||
Total Assets | 18.25B | 19.07B | 19.63B | 19.35B | 19.96B | |||||
Interest Expense | -124M | -110M | -107M | -57.88M | -36.89M | |||||
Income Tax Expense | 141M | 97.06M | 117M | 132M | 341M | |||||
CAPEX | -378M | -521M | -307M | -357M | -220M | |||||
EBT | 1.04B | 918M | 984M | 1.1B | 1.67B | |||||
D&A | 723M | 815M | 837M | 813M | 766M | |||||
Operating Income | 1.02B | 898M | 966M | 1.08B | 1.75B | |||||
Net Income | 649M | 568M | 628M | 692M | 1.08B | |||||
Raw Material | - | - | - | - | - | |||||
Information Service | - | - | - | - | - | |||||
Trading | - | - | - | - | - |
Geographical Revenue Distribution History
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
East China | 3.4B | 3.69B | 3.68B | 3.17B | 2.81B | |||||
Overseas | 2.3B | 2.84B | 2.49B | 2.47B | 2.58B | |||||
North China | 1.61B | 1.71B | 1.75B | 1.4B | 1.5B | |||||
Southern China | 1.43B | 1.57B | 1.2B | 1.28B | 1.11B | |||||
South-West China | 1.31B | 1.47B | 1.48B | 1.26B | 1.08B | |||||
Central China | 1.25B | 1.25B | 1.17B | 1.13B | 944M | |||||
North-West China | 561M | 564M | 541M | 573M | 422M | |||||
North-East China | 540M | 669M | 502M | 514M | 397M |
Select your edition
All financial news and data tailored to specific country editions
